BlackRock related stories
All articles and analysis
GPs are reassessing strategies amid the threat of inflationWhile inflation has caused GPs to look hard at portfolio companies' pricing power, it is not necessarily bad for private equity in the long run.
Side Letter: PEI Awards – vote now; Europe's mid-market madness; Cbus cuts costsTime to vote for the firms, investors, intermediaries, deals, lawyers and funds you think deserve recognition after a heady year for private equity. Plus: Highlights from Europe's crowded mid-market and Aussie pension Cbus is on a mission to cut costs. Here's today's brief, for our valued subscribers only.
The challenges preventing retail potential from turning into alternatives AUMWith retail investing in alternatives still in its infancy, headwinds remain before the $179trn global pool of individual investor capital can be fully tapped.
Best of Friday Letters 2021In a year when there was no shortage of developments to dissect, here are five of our favourite editorial commentaries from the last 12 months.
Side Letter: PE's 'third leg'; KKR's BlackRock hire; CalPERS' job huntPrivate equity firms are embracing bolt-ons in a bid to blend down their entry valuations. Plus: KKR has appointed a former BlackRock managing director in Asia and CalPERS is seeking a co-investment whiz. Here's today's brief, for our valued subscribers only.
eFront: Untapping pension plans’ private markets potentialWith the cap on alternatives now lifted, UK pension funds are eyeing private markets. But the operational challenges should not be overlooked, says BlackRock’s Melissa Ferraz.
Side Letter: EU's ELTIF overhaul; PE's movie premiere; Didi to delist?The European Commission wants to help more retail investors access the private markets. Plus: Invest Europe has produced a new film series exploring the ways private equity touches lives and LP appetites for China might have suffered another setback. Here's today's brief, for our valued subscribers only.
Side Letter: EQT's healthcare drive; BlackRock's insurer insight; Apax's $1bn targetEQT won't rule out a life sciences growth fund in its bid to develop a healthcare ecosystem. Plus: Insight from BlackRock's latest insurer survey and Apax wants $1 billion for its debut impact fund. Here's today's brief, for our valued subscribers only.
Side Letter: PE's dry powder keg?; GA's wealthy LPs; ILPA's template tweaksAn insight into the amount of dry powder held by private equity's blue chips. Plus: General Atlantic taps wealthy individuals and ILPA tweaks its DE&I template. Here's today's brief, for our valued subscribers only.
Key trends in impact investingFrom new entrants and approaches to increasingly pressing challenges, the impact investing market continues to grow and become more nuanced.